Annual Report for the year ended 30 June 2009
   
 
   
search  
 
Decrease font size | Increase font size | | |
 
Group overview  
 
     
 
  • Aspen has businesses in South Africa, Australia, India, Cyprus, Brazil, Mexico, Venezuela, Kenya, Tanzania, Uganda, Mauritius, Dubai and the United Kingdom.
  • Aspen is listed on the JSE Ltd and is Africa’s largest pharmaceutical manufacturer.
  • Aspen is a supplier of branded and generic pharmaceuticals in approximately 100 countries across the globe and of consumer and nutritional products in selected territories.
  • Aspen is a leading generics manufacturer in the southern hemisphere.
  • Aspen is a leading supplier of generic medicines to both the private and the public sectors in
    South Africa.
  • Aspen is one of the top 20 generic manufacturers worldwide and South Africa’s number one generic brand.
  • Aspen has 14 pharmaceutical manufacturing facilities at 10 pharmaceutical manufacturing sites on three continents. Four of the sites are located in South Africa, one in India, two in East Africa and three in Latin America.
  • Aspen has production capabilities for a wide variety of product types including tablets, capsules, steriles, injectables, penicillins, penems, infant milk formulations (“IMFs”), liquids and creams.
  • Aspen is one of the leading global players in generic antiretrovirals (“ARVs”).
  • Aspen has an outstanding generic pipeline. These products are developed under the direction of highly skilled scientists employed by Aspen and in collaboration with other global pharmaceutical companies and research facilities.
  • Aspen products are renowned for their quality, efficacy and affordability.
 
Back to top